The CBD Industry's Biggest Lies (And What the Truth Is) | PureCraft CBD

By the PureCraft CBD Editorial Team  |  Updated 2026  |  12 min read

Why This Post Exists

The CBD industry has a misinformation problem that its participants are largely responsible for creating. In the absence of mandatory pre-market FDA review, marketing claims have outrun evidence, technical terminology has been appropriated without technical standards, and the gap between what is claimed and what is verifiable has grown wide enough to significantly harm consumer trust in an otherwise legitimate category.

This post names the specific misleading claims that are most prevalent in CBD marketing — not to condemn the entire industry, but because the most trustworthy thing a CBD company can do is tell you honestly where the industry misleads people, and then show you how to verify what's actually true. We include our own category in the scrutiny where relevant.

Lie #1: "Full-Spectrum Is Always Better Than Broad-Spectrum"

The claim: Full-spectrum CBD contains the complete plant profile including THC, producing a superior "entourage effect" that broad-spectrum CBD cannot match because THC is an essential component of the synergy.

The truth: The entourage effect hypothesis — that cannabinoids work synergistically — is supported by evidence. The claim that this entourage requires THC is not. The most comprehensive review of entourage effect evidence (Russo 2011) identified terpene-cannabinoid interactions and minor cannabinoid synergies as the primary entourage mechanisms — not specifically THC. Broad-spectrum CBD retains these mechanisms while eliminating THC.

Why companies make this claim: Full-spectrum extract is simpler and cheaper to produce than broad-spectrum — it doesn't require the additional chromatographic THC removal step. "Full-spectrum is better" conveniently justifies the less expensive production process as a premium characteristic.

The honest position: Full-spectrum has the complete plant profile including THC. Broad-spectrum has the complete plant profile minus THC. For people with no drug testing concern and no THC sensitivity, full-spectrum is a reasonable choice. For everyone else — which is most people — broad-spectrum provides comparable entourage benefit without the THC risks. The hierarchy claim ("full-spectrum is superior") is not supported by evidence.

Lie #2: "10mg of CBD Is 10mg of CBD, Regardless of Brand"

The claim (implicit): When comparing CBD products, milligrams are a meaningful unit of comparison — 10mg from Brand A equals 10mg from Brand B.

The truth: Label claims are unverified assertions in the absence of COA confirmation. Bonn-Miller et al. (2017, JAMA) found that 26% of CBD products tested contained substantially less CBD than labeled. Additionally, bioavailability varies dramatically by formulation — 10mg of standard swallowed oil may deliver 0.6–1.9mg to systemic circulation, while 10mg of genuine nanoemulsified CBD may deliver 4–6.5mg. Same label claim; profoundly different effective doses.

Why this matters: Consumers comparing CBD products by price per milligram are comparing unverified label claims across wildly different bioavailability profiles. A cheaper product with 20mg per serving that delivers 10% bioavailability delivers 2mg to your bloodstream; a more expensive product at 15mg with 50% bioavailability delivers 7.5mg — nearly 4x more for 25% fewer labeled milligrams.

The honest position: CBD milligrams on a label require COA verification for accuracy and formulation context for meaningful comparison. Price per milligram is only a useful comparison metric after both conditions are confirmed.

Lie #3: "Pharmaceutical Grade" Is a Meaningful Standard for Supplements

The claim: "Pharmaceutical grade CBD" — a phrase that appears on dozens of CBD brands' packaging and marketing — implies the product has met pharmaceutical quality standards.

The truth: "Pharmaceutical grade" is not a regulated term for dietary supplements. There is no FDA-defined standard called "pharmaceutical grade" for supplement products. The only pharmaceutical-grade CBD that exists is Epidiolex — an FDA-approved drug that underwent years of clinical trials, manufacturing inspections, and regulatory review before approval. Applying the term "pharmaceutical grade" to a CBD supplement is marketing language that appropriates pharmaceutical regulatory credibility without the actual regulatory oversight pharmaceutical approval entails.

The honest position: CBD supplements are not pharmaceutical products regardless of how they're labeled. The quality standards that matter — ISO/IEC 17025 accredited third-party testing, GMP manufacturing practices, batch-specific COA documentation — are real and verifiable. "Pharmaceutical grade" is not.

Lie #4: "Nano CBD" Without Actual Nanoemulsion

The claim: "Nano CBD," "nano-enhanced," "nano-amplified," and similar terms imply that the CBD has been processed to nanoscale particle sizes producing dramatically improved bioavailability.

The truth: "Nano" has been adopted as a marketing term applied to products across the spectrum from genuine nanoemulsion (<100nm particle size) to simple surfactant emulsification that makes CBD water-miscible but doesn't achieve nanoscale particle sizes. Many "nano CBD" products have never had their particle size measured; others have been measured and found to have particle sizes in the microemulsion range (100–1000nm), not the nanoscale range that produces the documented bioavailability improvement.

The test: Ask any "nano CBD" brand for their particle size documentation in nanometers from dynamic light scattering (DLS) analysis. The inability or unwillingness to provide this data strongly suggests the "nano" claim is marketing language rather than verified nanotechnology.

The honest position: Genuine nanoemulsion CBD exists, provides documented bioavailability improvement, and requires particle size verification to confirm. Without particle size documentation below 100nm, "nano" is an unverified marketing claim.

Lie #5: "Organic" When Not USDA Certified

The claim: "Organic hemp," "grown organically," "organic CBD" — suggesting the product meets USDA Organic standards.

The truth: USDA Organic is a legally defined term — using it without USDA Organic certification and the presence of the official USDA Organic seal is a labeling violation. However, companies use "organic" as a general descriptor for farming practices without pursuing certification — calling their hemp "grown organically" without the USDA seal in ways that create an organic impression without legal accountability to that standard. The word "organic" in a brand name or product description without the USDA seal is a marketing choice, not a certification claim.

The honest position: If a CBD product has USDA Organic certification, it will display the USDA Organic seal and name the certifying agent. Without these, "organic" is a marketing adjective. The honest alternative to organic claims is pesticide COA testing — which directly verifies pesticide absence regardless of farming practice labels.

Lie #6: "Third-Party Tested" as a Quality Credential

The claim: "Third-party tested" on CBD packaging implies rigorous independent quality verification.

The truth: "Third-party tested" is the most widely used and least meaningful quality claim in CBD. It tells you that some lab tested something about this product at some point. It says nothing about: whether the lab is accredited; whether the test covered the full panel (potency + heavy metals + pesticides + solvents + microbials) or just cannabinoid potency; whether the COA is batch-specific to the product you're holding or a generic brand-level document; whether the testing occurred recently or years ago; or whether the results were favorable.

A company that has done rigorous third-party testing doesn't just say "third-party tested" — it provides the COA. The claim is a substitute for transparency, not evidence of it. Any company that uses "third-party tested" as a quality badge without making the actual COA easily accessible is using the claim to imply what the documentation would actually prove.

The honest position: "Third-party tested" means nothing without the COA. Demand the COA, evaluate it against the criteria in P7-32, and treat the claim as unverified until the COA confirms it.

Lie #7: "CBD Cures / Treats / Prevents" Anything

The claim: Explicit or implied disease treatment claims — CBD for cancer, CBD for Alzheimer's, CBD cures anxiety disorder — appearing in product descriptions, website copy, or social media.

The truth: CBD has documented mechanistic relevance to multiple physiological systems and growing clinical trial evidence for anxiety, sleep, and certain pain conditions. It is not a cure, treatment, or prevention for any disease outside of the two epilepsy syndromes for which Epidiolex is FDA-approved. Disease treatment claims for CBD supplements are prohibited by FDA regulations — not because CBD has no effect, but because the evidence does not support the disease treatment standard required for such claims, and because making them is dishonest to consumers who may delay appropriate medical treatment in favor of a supplement.

The honest position: CBD supports specific physiological mechanisms with evidence of varying quality for various applications. It is not a pharmaceutical and cannot legally or honestly claim to treat disease. The structure/function claim framework — "supports a calm stress response," "promotes relaxation," "helps maintain healthy sleep" — is both legally appropriate and more honestly calibrated to what the evidence actually shows.

Lie #8: "No Side Effects"

The claim: CBD is completely safe with no side effects — a claim appearing across a significant portion of CBD marketing.

The truth: CBD has a favorable safety profile with rare and generally mild adverse effects at supplement doses — but "no side effects" is not accurate. Documented side effects at supplement doses include: mild GI upset (particularly on empty stomach), mild somnolence at higher doses, mild appetite changes, and potential drug interactions via CYP3A4/CYP2C9 inhibition with certain medications. At high doses (above 100mg), liver enzyme elevation has been documented. CBD also interacts with warfarin in a way that can be clinically significant. "No side effects" is a safety overclaim that fails the consumer who needs accurate information to make informed decisions about combinations with medications or health conditions.

The honest position: CBD has a favorable safety profile with a low incidence of adverse effects at supplement doses in most healthy adults. For people on CYP3A4-metabolized medications, the drug interaction potential warrants physician disclosure. "Generally well-tolerated" is accurate; "no side effects" is not.

Lie #9: "Legal Everywhere"

The claim: Hemp CBD is federally legal and therefore legal everywhere in the United States (or globally).

The truth: Hemp-derived CBD is federally legal under the 2018 Farm Bill in the US. However, some US states (Idaho, Iowa, South Dakota) have state-level restrictions that complicate legal status locally. Internationally, CBD's legal status varies dramatically — from broadly legal (Canada, UK with restrictions, Germany with prescriptions) to strictly prohibited (many Asian and Middle Eastern countries). "Legal everywhere" is geographically incorrect and has led some consumers and businesses into legal exposure in states and countries where it's not.

The honest position: Hemp CBD is federally legal in the US under the 2018 Farm Bill. State laws vary and a handful of states have additional restrictions. Internationally, verify the specific country's regulations before traveling with CBD or marketing internationally.

Lie #10: "This Batch's COA" Attached to an Old Test

The claim: A COA is presented as documenting the quality of the product you're buying.

The truth: Without a batch number on the COA that matches the lot number on your specific product, the COA documents a previous batch's quality — which may or may not represent the current product. Some companies display the same COA for years while product formulations and suppliers change. Others display COAs from their "best" batch rather than the current production batch. A COA that isn't batch-specific to the product you're purchasing tells you nothing verifiable about that product.

The honest position: Batch-specific COAs — where the lot number on the COA matches the lot number on the product — are the only meaningful quality documentation. Generic brand-level COAs are documentation theater.

The Common Thread: Impressive-Sounding, Unverifiable Claims

Looking across these ten deceptions, the common pattern is clear: each involves a claim that sounds technically credible, invokes regulatory or scientific authority, and is difficult for the average consumer to investigate or refute. The defense against all of them is the same: demand the specific documentation that would either confirm or refute the claim — the batch COA for potency and contaminant claims, the particle size certificate for nano claims, the USDA Organic seal for organic claims, the specific clinical trial citation for efficacy claims.

Claims that can't be documented should be treated as marketing rather than verified quality attributes. The CBD companies worth your trust are the ones who provide the documentation rather than expecting you to take the claim at face value.

PureCraft's Commitment: Claims We Make and How to Verify Them

• "Zero THC": Verifiable via batch COA showing delta-9-THC at ND with LOQ ≤0.01% — not just "below 0.3%." See your batch COA.
• "Broad-spectrum": Verifiable via batch COA showing multiple minor cannabinoids (CBG, CBC, CBN) alongside CBD, with THC at ND — not just CBD with a broad-spectrum label.
• "Nano-optimized": Particle size documentation available — high-pressure homogenization to <100nm, verified by DLS analysis. Ask us for this.
• CBD mg per serving: COA-verified within ±10% of labeled claim — not an unverified label assertion.
• We don't claim "pharmaceutical grade," "no side effects," "cures" or "treats" anything, "organic" without certification, or "legal everywhere." These are the claims we've documented as misleading, and we don't make them.

PureCraft CBD Oil and CBD+CBN Sleep Gummies. Batch COA. Browse all PureCraft CBD products.